Related Experiment Video
Updated: Aug 15, 2026
07:43
Methods to Enable Spatial Transcriptomics of Bone Tissues
Published on: May 3, 2024
Expression profiles of osteosarcoma that can predict response to chemotherapy
Tsz-Kwong Man1, Murali Chintagumpala, Jaya Visvanathan
1Department of Pediatrics, Texas Children's Cancer Center, Houston, Texas, USA.
Cancer Research
|September 17, 2005
Summary
Predicting pediatric osteosarcoma treatment response early is crucial. Gene expression profiling identified 45 genes that accurately predict patient response to chemotherapy, enabling tailored treatment strategies for better outcomes.
Area of Science:
- Pediatric Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Osteosarcoma is the most common pediatric bone cancer.
- Treatment response to chemotherapy is a key prognostic factor.
- Current methods cannot reliably predict poor responders at diagnosis.
Purpose of the Study:
- To identify genes that predict chemotherapy response in pediatric osteosarcoma.
- To develop a classifier for early prediction of treatment outcomes.
Main Methods:
- Expression profiling of 34 pediatric osteosarcoma samples.
- Identification of 45 discriminating genes using t-tests (P < 0.005).
- Development and testing of a support vector machine classifier.
Main Results:
- A classifier achieved 83% accuracy in classifying initial biopsy samples.
- Independent testing showed 100% accuracy in predicting treatment response.
- Identified genes are involved in bone development, drug resistance, and tumorigenesis.
Conclusions:
- Gene expression profiling can accurately predict chemotherapy response in osteosarcoma.
- Early prediction allows for personalized therapy development for poor responders.
- This approach may improve outcomes for children with osteosarcoma.
